105
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

High NF-E2-related factor 2 expression predicts poor prognosis in patients with lung cancer: a meta-analysis of cohort studies

, , , , , , , & show all
Pages 790-798 | Received 18 Jun 2019, Accepted 01 Jul 2019, Published online: 24 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuji Naito, Koji Uchida & Shinya Toyokuni. (2020) The new era for redox research. Free Radical Research 54:11-12, pages 787-789.
Read now

Articles from other publishers (3)

Qi Kong, Hanyi Deng, Chunchun Li, Xiaojuan Wang, Yasuyo Shimoda, Shasha Tao, Koichi Kato, Jie Zhang, Kenzo Yamanaka & Yan An. (2021) Sustained high expression of NRF2 and its target genes induces dysregulation of cellular proliferation and apoptosis is associated with arsenite-induced malignant transformation of human bronchial epithelial cells. Science of The Total Environment 756, pages 143840.
Crossref
Holly Robertson, Albena T. Dinkova-Kostova & John D. Hayes. (2020) NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. Cancers 12:12, pages 3609.
Crossref
Shinji Goto, Tsuyoshi Kawabata & Tao-Sheng Li. (2020) Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance. Stem Cells International 2020, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.